Company Filing History:
Years Active: 1990-1998
Title: The Innovations of Thomas F Bumol
Introduction
Thomas F Bumol is a notable inventor based in Carmel, IN (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 8 patents, showcasing his innovative approach to addressing significant health issues. His work primarily focuses on methods for treating substance abuse withdrawal and improving tissue repair.
Latest Patents
Among his latest patents is a method for treating substance abuse withdrawal. This invention provides a method for treating a condition resulting from the cessation or withdrawal of tobacco or nicotine, opioids, ethanol, or combinations thereof. It comprises administering an effective amount of 4-chloro-5-(imidazoline-2-yl(amino)-6-methoxy-2-methylpyrimidine. Another significant patent involves methods of inhibiting imperfect tissue repair. This method addresses a physiological condition due at least in part to imperfect tissue repair by administering an effective amount of a specific compound.
Career Highlights
Thomas F Bumol is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the medical field. His innovative methods have the potential to significantly impact the treatment of substance abuse and tissue repair.
Collaborations
Throughout his career, Thomas has collaborated with several talented individuals, including Robert Alan Gadski and Lisa Selsam Beavers. These collaborations have fostered a creative environment that encourages the development of innovative solutions in healthcare.
Conclusion
Thomas F Bumol's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for advancements in treatment methods, making a significant impact on public health.